Redwood City, CA, United States of America

Louis C Sehl

This inventor holds 15 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Biomaterials Research. Top assignees: Onyx Therapeutics, Inc., Angiodevice International Gmbh, Cohesion Technologies, Inc.. Active years: 2002-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis C Sehl. Retrieved from https://idiyas.com/inventor/louis-c-sehl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 53.3


 

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 512(Granted Patents)


Company Filing History:


Years Active: 2002-2016

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Protease Inhibitors
Biomaterials
Tissue Repair
Crosslinked Compositions
Adhesive Materials
Crystalline Peptides
Amino Acid Keto-Epoxides
Collagen Sheets
Ecarin Prothrombin
Synthesis Methods
15 patents (USPTO):Explore Patents

Sure, I can help you with that! Here's the article about inventor Louis C Sehl based on the information provided:

Title: Inventor Spotlight: Louis C Sehl - Pioneering Innovations in Redwood City, CA

Introduction:

Louis C Sehl, a visionary inventor based in Redwood City, CA, has made significant contributions to the field of pharmaceuticals with a total of 15 patents to his name. His groundbreaking work in the development of crystalline tripeptide epoxy ketone protease inhibitors has paved the way for advancements in the realm of pharmaceutical compositions.

Latest Patents:

Louis C Sehl's latest patents revolve around crystalline tripeptide keto epoxide compounds and their methods of preparation. These innovative compounds have vast implications in the field of pharmaceuticals and offer new avenues for the development of novel treatments.

Career Highlights:

Throughout his career, Louis C Sehl has been associated with renowned companies such as Onyx Therapeutics, Inc. and Angiodevice International GmbH. His expertise and dedication have been instrumental in driving forward cutting-edge research and development within these organizations, leading to impactful innovations in the medical industry.

Collaborations:

Louis C Sehl has had the privilege of collaborating with esteemed individuals in the field, including Olof Mikael Trollsas and Jacqueline Anne Schroeder. Together, they have worked on pioneering projects that have pushed the boundaries of pharmaceutical science and brought forth revolutionary advancements.

Conclusion:

In conclusion, Louis C Sehl stands as a prominent figure in the world of inventions and innovations, with his impressive portfolio of patents and groundbreaking research. His dedication to advancing pharmaceutical technologies has not only transformed the industry but has also paved the way for future breakthroughs in medicinal treatments.

If you have any more requests or need further information, feel free to let me know!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…